Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1

摘要

Pharmaceutical compositions containing oxandrolone and a pharmaceutically acceptable carrier are provided for ameliorating myopathy, weight loss or muscle wasting resulting from human immunodeficiency virus type-1 infection, wherein the oxandrolone is present in the composition in an amount of 7.5 milligrams or more.